Table 4.
Method | Setting / scenariob | 5-year Relative Survival (RS) | Loss in life expectancy (LLE)a,g | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
PE | SE | LCI | UCI | RPc | PE | SE | LCI | UCI | RP | ||
men, 55 years at diagnosis | |||||||||||
Conventionald | 1Sf | 0.639 | 0.102 | 0.406 | 0.801 | 0.00 | 11.28 | 3.08 | 5.24 | 17.31 | 0.00 |
Bootstrap-basede | E | 0.639 | 0.102 | 0.405 | 0.801 | 0.01 | 11.28 | 3.08 | 5.24 | 17.31 | 0.03 |
men, 65 years at diagnosis | |||||||||||
Conventional | 1S | 0.670 | 0.072 | 0.507 | 0.790 | 0.00 | 7.47 | 1.50 | 4.53 | 10.41 | 0.00 |
Bootstrap-based | E | 0.670 | 0.072 | 0.507 | 0.790 | 0.00 | 7.47 | 1.50 | 4.53 | 10.41 | 0.06 |
men, 75 years at diagnosis | |||||||||||
Conventional | 1S | 0.510 | 0.075 | 0.357 | 0.644 | 0.00 | 5.81 | 0.72 | 4.39 | 7.23 | 0.00 |
Bootstrap-based | E | 0.510 | 0.075 | 0.357 | 0.644 | 0.00 | 5.81 | 0.72 | 4.39 | 7.23 | 0.16 |
men, 85 years at diagnosis | |||||||||||
Conventional | 1S | 0.619 | 0.100 | 0.394 | 0.781 | 0.00 | 1.74 | 0.44 | 0.88 | 2.60 | 0.00 |
Bootstrap-based | E | 0.619 | 0.101 | 0.394 | 0.781 | 0.03 | 1.74 | 0.44 | 0.88 | 2.60 | 0.18 |
women, 55 years at diagnosis | |||||||||||
Conventional | 1S | 0.672 | 0.099 | 0.440 | 0.825 | 0.00 | 8.83 | 2.89 | 3.17 | 14.49 | 0.00 |
Bootstrap-based | E | 0.672 | 0.099 | 0.440 | 0.825 | 0.00 | 8.83 | 2.89 | 3.17 | 14.49 | 0.00 |
women, 65 years at diagnosis | |||||||||||
Conventional | 1S | 0.701 | 0.060 | 0.566 | 0.801 | 0.00 | 6.49 | 1.47 | 3.61 | 9.37 | 0.00 |
Bootstrap-based | E | 0.701 | 0.060 | 0.566 | 0.801 | 0.00 | 6.49 | 1.47 | 3.61 | 9.37 | 0.04 |
women, 75 years at diagnosis | |||||||||||
Conventional | 1S | 0.550 | 0.082 | 0.377 | 0.693 | 0.00 | 5.98 | 1.05 | 3.92 | 8.05 | 0.00 |
Bootstrap-based | E | 0.550 | 0.082 | 0.377 | 0.693 | 0.00 | 5.98 | 1.05 | 3.92 | 8.05 | 0.07 |
women, 85 years at diagnosis | |||||||||||
Conventional | 1S | 0.653 | 0.082 | 0.470 | 0.787 | 0.00 | 1.89 | 0.46 | 0.98 | 2.80 | 0.00 |
Bootstrap-based | E | 0.653 | 0.082 | 0.470 | 0.787 | 0.03 | 1.89 | 0.46 | 0.98 | 2.80 | 0.11 |
men, 55 years at diagnosis | |||||||||||
Conventionald | 2Sf | 0.637 | 0.103 | 0.404 | 0.800 | 0.00 | 11.49 | 3.12 | 5.38 | 17.60 | 0.00 |
Bootstrap-basede | J | 0.637 | 0.102 | 0.404 | 0.800 | -0.01 | 11.49 | 3.12 | 5.38 | 17.61 | 0.05 |
men, 65 years at diagnosis | |||||||||||
Conventional | 2S | 0.668 | 0.072 | 0.505 | 0.788 | 0.00 | 7.65 | 1.54 | 4.64 | 10.66 | 0.00 |
Bootstrap-based | J | 0.668 | 0.072 | 0.505 | 0.788 | 0.00 | 7.65 | 1.54 | 4.63 | 10.67 | 0.16 |
men, 75 years at diagnosis | |||||||||||
Conventional | 2S | 0.509 | 0.074 | 0.356 | 0.643 | 0.00 | 6.03 | 0.75 | 4.56 | 7.51 | 0.00 |
Bootstrap-based | J | 0.509 | 0.074 | 0.356 | 0.643 | 0.00 | 6.03 | 0.76 | 4.55 | 7.51 | 0.62 |
men, 85 years at diagnosis | |||||||||||
Conventional | 2S | 0.612 | 0.100 | 0.389 | 0.774 | 0.00 | 1.88 | 0.47 | 0.96 | 2.79 | 0.00 |
Bootstrap-based | J | 0.612 | 0.100 | 0.389 | 0.774 | 0.01 | 1.88 | 0.47 | 0.96 | 2.80 | 0.50 |
women, 55 years at diagnosis | |||||||||||
Conventional | 2S | 0.673 | 0.098 | 0.443 | 0.825 | 0.00 | 8.93 | 2.94 | 3.17 | 14.69 | 0.00 |
Bootstrap-based | J | 0.673 | 0.098 | 0.443 | 0.825 | -0.01 | 8.93 | 2.94 | 3.17 | 14.69 | 0.03 |
women, 65 years at diagnosis | |||||||||||
Conventional | 2S | 0.702 | 0.060 | 0.567 | 0.802 | 0.00 | 6.59 | 1.50 | 3.64 | 9.54 | 0.00 |
Bootstrap-based | J | 0.702 | 0.060 | 0.567 | 0.802 | 0.00 | 6.59 | 1.50 | 3.65 | 9.54 | 0.06 |
women, 75 years at diagnosis | |||||||||||
Conventional | 2S | 0.553 | 0.082 | 0.380 | 0.695 | 0.00 | 6.17 | 1.11 | 4.00 | 8.33 | 0.00 |
Bootstrap-based | J | 0.553 | 0.082 | 0.380 | 0.695 | 0.00 | 6.17 | 1.11 | 4.00 | 8.33 | 0.14 |
women, 85 years at diagnosis | |||||||||||
Conventional | 2S | 0.649 | 0.081 | 0.467 | 0.783 | 0.00 | 2.03 | 0.50 | 1.05 | 3.01 | 0.00 |
Bootstrap-based | J | 0.649 | 0.081 | 0.467 | 0.783 | 0.00 | 2.03 | 0.50 | 1.05 | 3.01 | 0.20 |
aLLE is presented in years
bSee Table 1 for information on the different settings and scenarios
cRP is presented in %
dConventional refers to the standard method for estimating SEs, where the general population mortality is assumed to be measured without uncertainty
eBootstrap-based refers to the parametric bootstrap approach used for including uncertainty in population mortality rates in the estimation of SEs
fS stands for small and refers to the setting to investigate what would be observed for a smaller population
gLLE estimates in setting 2S and scenario J are presented for the Stockholm region